AbbVie Inc. Annual Operating Income (Loss) in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
AbbVie Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2023.
  • AbbVie Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was $4B, a 11.4% decline year-over-year.
  • AbbVie Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was $12.3B, a 29.4% decline year-over-year.
  • AbbVie Inc. annual Operating Income (Loss) for 2023 was $12.8B, a 29.6% decline from 2022.
  • AbbVie Inc. annual Operating Income (Loss) for 2022 was $18.1B, a 1.08% increase from 2021.
  • AbbVie Inc. annual Operating Income (Loss) for 2021 was $17.9B, a 57.7% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $12.8B -$5.36B -29.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-20
2022 $18.1B +$193M +1.08% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-20
2021 $17.9B +$6.56B +57.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
2020 $11.4B -$1.62B -12.5% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-17
2019 $13B +$6.6B +103% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-18
2018 $6.38B -$3.16B -33.1% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-19
2017 $9.55B +$205M +2.2% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-21
2016 $9.34B +$1.8B +23.9% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $7.54B +$4.13B +121% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-16
2014 $3.41B -$2.25B -39.8% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-17
2013 $5.66B -$153M -2.63% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-19
2012 $5.82B +$2.2B +60.7% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-20
2011 $3.62B Jan 1, 2011 Dec 31, 2011 10-K 2014-02-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.